INTRODUCTION
Parkinson's disease (PD) is a multisystem degenerative disorder which is characterized by a combination of motor and non-motor symptoms (1, 2) . Nonmotor symptoms include: depression, cognitive impairment, autonomic and sensor symptoms (2, 3) . It can be very complicated to identify depression in PD patients who have cognitive impairment, for known depression scales are not reliable markers to evaluate depression (4) . Dementia is present in more than 30% of PD patients, especially in those over 70 years old (5, 6) . Depression and dementia are often connected comorbidities; however, depression can be considered a risk factor for dementia development in PD (7) . Early depression identification and treatment can significantly improve the quality of life in PD patients, as well as facilitate the quality of caregivers' lives (7) (8) (9) (10) . Depression may appear as one of the first symptoms of PD, but it can appear many years before the beginning of motor symptoms of the illness. Dementia in PD implies impairment of executive function, attention, slow cognitive speed, recalling learned information, and visuospatial problem (11) . Dementia is also a part of neurodegenerative illnesses, including PD (12) (13) (14) . Prevalence of major depression in PD patients is from 2.7% to 8.2% and from 13% to 34.5% in case of minor de- (20) . Depression is a very common in dementia as part of PD. Therefore, its early identification is of the essence in order to begin early medicament therapy, which will in the long-run improve the quality of life both of the patient and the caregiver (11, 16, 21) .
PATIENTS AND METHODS
We researched presence and degree of depression in patients with Parkinson's disease with cognitive impairment.
Patients that were tested are those who came for a regular check-up to Neurological infirmary of the General Hospital in Niksic, Montenegro, in the interval from 1 st January to 31 st December 2016, all previously diagnosed with idiopathic Parkinson's disease. We tested cognitive status in 59 patients with idiopathic Parkinson's disease, using the MMSE scale. Out of the 59 patients, 32 were included in the research, all of whom tested less than 23 points on the Mini Mental State Examination (MMSE). They were divided to three groups: with mild (20-23), moderate (11) (12) (13) (14) (15) (16) (17) (18) (19) , and severe cognitive deficit (0-10 points). After the applied MMSE testing, patients or caregivers of the patients received instructions about observing the patient in the next 7 days, when the testing with the Cornell's scale for depression would be applied (13). Cornell's scale for depression was applied on patients with dementia in order to achieve a more objective assessment. The scale consists of 19 parameters which are grouped into 5 groups: mood-related signs, behavioral disturbances, physical signs, cyclic functions and ideational disturbances. Each item is rated on a scale of 0-2 (0-absent, 1-mild or intermittent, 2-severe). Score above 10 indicates probable major depression; score above 18 indicates definite major depression; score below 6 as a rule is associated with absence of significant depressive symptoms (22) .
Scores are presented tabularly and in percentage. We used the Chi-square test to connect depression and cognitive impairment.
We researched the significance of the Cornell scale in detecting depression in PD patients.
Ethics Statement: The paper was approved by the Ethical committee of the hospital where we did the research, and all the patients signed the informational consent before the beginning of research. Table 3) .
RESULTS

Out
Out of 8 patients with probable depression 3 (9.4%) had mild, 3 (9.4%) had moderate and 2 (6.2%) distinct cognitive deficit. We can also conclude that out of 19 (59.4%) with certain depression, 1 (3.1%) had mild, 5 (15.6%) had moderate, and 13 (40.6%) had severe cognitive deficit (Table 4 ).There is a significant correlation between depression and cognitive impairment (Table 5 ). The size of the impact of depression on cognitive impairment is a high (Table 6) .
We feel that the Cornell Scale is greatly significant in identifying depression in these patients (Table 7) . The size of the impact of the 0,413 high. 
DISCUSSION
Patients with Parkinson's disease, in over 50% of the cases, suffer from significant cognitive impairment at a certain stage of the illness, which is in accordance with many previous studies (17) (18) (19) (20) . In case of our PD patients, with cognitive impairment, at a certain point of the illness, 25% probably suffer from major depression, and 59.4% definitely suffer from depression, which is more than in previously shown results in other studies (14-16).
Cornell's scale may help us in our daily work to early diagnose depression in PD patients with dementia, which is a prerequisite for early treatment of depression of these patients (22) .
Minimizing the disability includes treating not just motor symptoms, but treating also dementia, depression and psychosis. Therefore, identification of clinically relevant screening and diagnostic tools for depression and cognitive impairment are necessary in PD patients (22) (23) .
CONCLUSION
Depression and dementia are a common problem in PD patients. Their detection is highly significant to clinical practice. PD patients with cognitive impairment present a special difficulty in identifying depression.
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